CIC
IDYA icon

Cornercap Investment Counsel’s IDEAYA Biosciences IDYA Stock Holding History

Cornercap Investment Counsel’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-15,896
Closed -$219K – 592
2022
Q2 		$219K Buy
+15,896
New +$177K 0.04% 484

Other funds holding IDYA

LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Cornercap Investment Counsel's IDYA Position: Q3 2022 in Review

Cornercap Investment Counsel sold out of IDEAYA Biosciences (IDYA) in Q3 2022, closing a stake of 15,896 shares — an estimated $219K sold.

Cornercap Investment Counsel first reported a position in IDYA in Q2 2022 and held it in 1 quarter. The position peaked at $219K in Q2 2022. 112 funds tracked by Wall St. Rank hold IDYA as of Q3 2022.

  • Cornercap Investment Counsel reported no remaining IDEAYA Biosciences position as of Q3 2022 after selling out during the quarter.
  • Cornercap Investment Counsel sold 15,896 IDEAYA Biosciences shares in Q3 2022, an estimated $219K.
  • Cornercap Investment Counsel first reported a position in IDEAYA Biosciences in Q2 2022 and held it in 1 quarter.
  • Cornercap Investment Counsel's IDEAYA Biosciences position peaked at $219K in Q2 2022.
  • 112 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2022.

Based on Cornercap Investment Counsel's 13F filing for Q3 2022, filed 14 Nov 2022.